S SENSIBLE BIOTECHNOLOGIES
Live / Allowed — Published for opposition (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 01 Jun 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 79380667
- Mark type
- Design + words
- Filed
- 01 Jun 2023
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Marek Krizka
Goods and services
- Class 001 — Chemicals: Chemicals for use in biotechnological manufacturing processes; chemicals for use in biotechnological product development; enzymes derived from biotechnological processes for use in industry; cell culture media for use in the biotechnological industry for scientific and research use; cell culture reagents for scientific and research use; biological preparation for use in cell cultures other than for medical or veterinary use; chemical for use in biotechnological manufacturing processes for use in molecular separation processes other than for medical or veterinary use; chemical for use in biotechnological product development for use in molecular separation processes other than for medical or veterinary use; cultures of microbiotic organisms, other than for medical use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; cell culture media for microbiology for scientific and research purposes; biological preparations for use in science; biological preparations for use in industry; biological preparations for use in cell cultures, other than for medical or veterinary purposes
- Class 005 — Pharmaceuticals: Biotechnological preparations for use in cell cultures for medical purposes; cells for medical use; living cells for medical use
- Class 035 — Advertising and business services: Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
- Class 042 — Scientific and technological services: Biotechnology testing of pharmaceutical preparations for gene therapy, pharmaceuticals, chemicals and cell culture media; consulting services in the field of biotechnology; research and development in the pharmaceutical and biotechnology fields; writing of computer programs for biotechnological applications; development of measuring probes for biotechnological applications; research and development of new products in the field of biotechnology; designing equipment for the biotechnology industry; providing information on the subject of scientific research in the field of biochemistry and biotechnology; research in the field of cell engineering technology; cell culture services for scientific and research purposes, for others; analysis in the field of molecular biology, namely, messenger RNA analysis to diagnose and treat diseases like COVID-19, influenza, RSV, Zika, CMV, HIV, melanoma, lung cancer, pancreatic cancer, cystic fibrosis, propionic acidemia, methylmalonic acidemia, Fabry disease, Gaucher disease, heart disease, multiple sclerosis, Type 1 diabetes, rheumatoid arthritis, and various allergies; research relating to molecular sciences; contract research services relating to molecular sciences; microbiological testing of cell culture media, DNA and RNA to diagnose and treat diseases like COVID-19, influenza, RSV, Zika, CMV, HIV, melanoma, lung cancer, pancreatic cancer, cystic fibrosis, propionic acidemia, methylmalonic acidemia, Fabry disease, Gaucher disease, heart disease, multiple sclerosis, Type 1 diabetes, rheumatoid arthritis, and various allergies medical research; pharmaceutical research; biochemical analyses; biochemical research and development services in the field of messenger RNA to diagnose and treat diseases like COVID-19, influenza, RSV, Zika, CMV, HIV, melanoma, lung cancer, pancreatic cancer, cystic fibrosis, propionic acidemia, methylmalonic acidemia, Fabry disease, Gaucher disease, heart disease, multiple sclerosis, Type 1 diabetes, rheumatoid arthritis, and various allergies; laboratory analyses of materials, namely, DNA and RNA materials to diagnose and treat diseases like COVID-19, influenza, RSV, Zika, CMV, HIV, melanoma, lung cancer, pancreatic cancer, cystic fibrosis, propionic acidemia, methylmalonic acidemia, Fabry disease, Gaucher disease, heart disease, multiple sclerosis, Type 1 diabetes, rheumatoid arthritis, and various allergies; biochemical research; biochemical analysis; biochemical research and development; biological laboratory research; chemical laboratory research; laboratory testing of materials; laboratory research in the field of chemistry; DNA testing for scientific research purposes, namely, DNA screening, determining DNA mutations; chemical laboratory services; biological research laboratory services; genetic engineering services in the field of genetic diseases; chemical analysis; scientific research in the field of genetics and genetic engineering; research and development in the field of microorganisms and cells
Owner
Prosecution history
- 12 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Feb 2026 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 24 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
- 24 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 24 Jan 2026 — EXAMINERS AMENDMENT E-MAILED
- 24 Jan 2026 — EXAMINERS AMENDMENT -WRITTEN
- 07 Jul 2025 — NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
- 07 Jul 2025 — ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
- 07 Jul 2025 — ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED